Operative invasiveness does not affect the prognosis of patients with non-small cell lung cancer
Background: The relationship between operative invasiveness and the prognosis in non-small cell lung cancer (NSCLC) patients who have undergone surgery has been controversial.
Methods: Clinical data were analyzed for 463 NSCLC patients. Operative invasiveness was defined by wound length, operation time, and the postoperative C-reactive protein (postCRP) level. The operative approach was divided into video-assisted thoracic surgery (VATS) and thoracotomy.
Results: The wound length and operation time were significantly correlated with the postCRP level (correlation coefficient (CC) = 0.39, p<0.01; CC = 0.54, p<0.01, respectively). The postCRP level in the VATS group was significantly lower than that in the thoracotomy group (12.2 mg/dl vs 20.58 mg/dl, p<0.01). The relapse-free survival differed significantly based on wound length (p<0.01), operation time (p=0.01), CRP level (p<0.01), and operative approach (p<0.01). The carcinoembryonic antigen level (hazard ratio [HR], 1.58; p = 0.02), pathological stage (pStage) (HR, 2.57; p < 0.01), vascular invasion (HR, 1.95; p = 0.01), and preoperative CRP level (preCRP) (HR, 1.91; p < 0.01) were identified as significant prognostic factors for relapse-free survival in a multivariate analysis. Furthermore, the multivariate analysis showed that smoking history (HR, 2.36; p = 0.03), pStage (HR, 3.26; p < 0.01), and preCRP level were significant prognostic factors for overall survival.
Conclusion: Preoperative CRP level was associated with poor prognosis. Although the VATS approach might be less invasive procedure for NSCLC patients, operative invasiveness does not affect the prognosis.
Figure 1
Figure 2
Posted 18 Aug, 2020
On 12 Aug, 2020
On 10 Aug, 2020
On 09 Aug, 2020
On 09 Aug, 2020
On 04 Aug, 2020
On 27 Jul, 2020
On 26 Jul, 2020
On 26 Jul, 2020
On 24 Jul, 2020
Received 23 Jul, 2020
On 05 Jul, 2020
On 04 Jul, 2020
Received 04 Jul, 2020
On 02 Jul, 2020
On 01 Jul, 2020
Invitations sent on 01 Jul, 2020
On 30 Jun, 2020
On 30 Jun, 2020
On 26 Jun, 2020
Received 23 Jun, 2020
Received 18 Jun, 2020
Received 18 Jun, 2020
On 04 Jun, 2020
On 04 Jun, 2020
On 02 Jun, 2020
On 30 May, 2020
Invitations sent on 30 May, 2020
On 29 May, 2020
On 29 May, 2020
On 27 May, 2020
Operative invasiveness does not affect the prognosis of patients with non-small cell lung cancer
Posted 18 Aug, 2020
On 12 Aug, 2020
On 10 Aug, 2020
On 09 Aug, 2020
On 09 Aug, 2020
On 04 Aug, 2020
On 27 Jul, 2020
On 26 Jul, 2020
On 26 Jul, 2020
On 24 Jul, 2020
Received 23 Jul, 2020
On 05 Jul, 2020
On 04 Jul, 2020
Received 04 Jul, 2020
On 02 Jul, 2020
On 01 Jul, 2020
Invitations sent on 01 Jul, 2020
On 30 Jun, 2020
On 30 Jun, 2020
On 26 Jun, 2020
Received 23 Jun, 2020
Received 18 Jun, 2020
Received 18 Jun, 2020
On 04 Jun, 2020
On 04 Jun, 2020
On 02 Jun, 2020
On 30 May, 2020
Invitations sent on 30 May, 2020
On 29 May, 2020
On 29 May, 2020
On 27 May, 2020
Background: The relationship between operative invasiveness and the prognosis in non-small cell lung cancer (NSCLC) patients who have undergone surgery has been controversial.
Methods: Clinical data were analyzed for 463 NSCLC patients. Operative invasiveness was defined by wound length, operation time, and the postoperative C-reactive protein (postCRP) level. The operative approach was divided into video-assisted thoracic surgery (VATS) and thoracotomy.
Results: The wound length and operation time were significantly correlated with the postCRP level (correlation coefficient (CC) = 0.39, p<0.01; CC = 0.54, p<0.01, respectively). The postCRP level in the VATS group was significantly lower than that in the thoracotomy group (12.2 mg/dl vs 20.58 mg/dl, p<0.01). The relapse-free survival differed significantly based on wound length (p<0.01), operation time (p=0.01), CRP level (p<0.01), and operative approach (p<0.01). The carcinoembryonic antigen level (hazard ratio [HR], 1.58; p = 0.02), pathological stage (pStage) (HR, 2.57; p < 0.01), vascular invasion (HR, 1.95; p = 0.01), and preoperative CRP level (preCRP) (HR, 1.91; p < 0.01) were identified as significant prognostic factors for relapse-free survival in a multivariate analysis. Furthermore, the multivariate analysis showed that smoking history (HR, 2.36; p = 0.03), pStage (HR, 3.26; p < 0.01), and preCRP level were significant prognostic factors for overall survival.
Conclusion: Preoperative CRP level was associated with poor prognosis. Although the VATS approach might be less invasive procedure for NSCLC patients, operative invasiveness does not affect the prognosis.
Figure 1
Figure 2